Vermont to Receive $136K Drug Settlement with GlaxoSmithKline

CNBC -- Vermont’s attorney general says the state will receive $136,000 as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company sold defective drugs.

MORE ON THIS TOPIC